Together these results demonstrate that either CLOCK activation domain (AD) fusion cDNA library from human or MOP4, free or in its dimeric complex with BMAL1, aortic vascular smooth muscle cells ( Figure 1A) . We also can associate with the ligand binding domain (LBD) tested RXR␣ and RAR␣ for possible interactions with of nuclear receptors in vitro and in vivo in a ligandfull-length cDNAs for MOP4, CLOCK, and BMAL1 beenhanced manner. cause of the high homology shared by MOP4 and CLOCK and the fact that both proteins can heterodimerize with BMAL1. Both RXR␣ and RAR␣ interacted Mapping of the Nuclear Receptor Interaction Domains of CLOCK and MOP4 strongly with CLOCK and MOP4, but not their heterodimeric partner, BMAL1, indicating the specificity of the We generated the N-and C-terminal truncation mutants of both CLOCK and MOP4 as Gal4BD fusions (Figure interaction. Similarly, no interaction was observed between MOP4, CLOCK, or BMAL1 and other nuclear re-3A) and used them in mammalian two-hybrid assays to map broadly the nuclear receptor interaction domain ceptor constructs which were analyzed ( Figure 1A) .
A liquid ␤-galactosidase activity assay was utilized to (NRID . Following addition of 50% serum for 2 hr, hPer2 mRNA was induced very rapidly at T4 (4 hr after serum Retinoic Acid Phase Shifts PER2 mRNA Rhythms shock) and entered a cyclical expression pattern, peakLiganded nuclear receptors interact with CLOCK and ing at T24 and T48 ( Figure 7A , panels I and II). All-trans-MOP4 to prevent their E box-mediated gene activation. retinoic acid (tRA) was added to the serum induced cells This suggests that circadian variability or periodic availat four different time points, T6, T12, T18, and T24 for ability in steroid hormones and vitamins, such as reti-2 hr intervals. Treatment at T12 delayed the hPer2 mRNA noids, might phase shift or reset a peripheral clock in from T24 to T28 ( Figure 7A , panels I and IIc). tRA treatthe vasculature. We first determined whether oscillating clock gene expression could be induced by serum shock ment at T6 and T24, however, had no effect on the hPer2 peak ( Figure 7A , panels I, IIb, and IIe). The effect of tRA tential importance in both vascular physiology and clinical vascular events. when administered at T18 was similar to treatment at A novel finding in this study is that MOP4 is an intrinsic T12; the hPer2 peak was phase-shifted by 4 hr and component of the clock system, at least in the vasculapeaked at T28. Consistent with a 4 hr shift, the second ture. The expression of MOP4 is reportedly absent in cycle peaked at T52 ( Figure 7A, panels I Figures 1 and 5) .
drive E box-mediated Per transcription. It remains to We performed the tRA phase shift experiment in the be determined whether this effect is restricted to the presence of cyclohexamide ( Figure 7B, panel I) , to deterperiphery or is also operant in the brain. Involvement of mine whether the effect of ligand-bound RXR␣ and MOP4 in this peripheral oscillator, but not in the SCN RAR␣ on MOP4/CLOCK function is direct and indepenclock, illustrates that some components of the feedback dent of protein synthesis. VSMC were pretreated with loop exhibit tissue-specific expression, perhaps facilicyclohexamide at T17, 1 hr before treatment with tRA. tating site-specific responses to humoral stimuli. DexaAnalysis of the hPer2 oscillation demonstrated that methasone, which has been recently reported to phase cyclohexamide did not prevent tRA from phase delaying shift the mPer rhythm in peripheral organs (Balsalobre et the hPer2 oscillation to T28 ( Figure 7B, panel I) . Cycloal., 2000), phase advances hPer2 in our system, whereas hexamide treatment alone had a minimal effect on the tRA phase delays the Per2 oscillation. These results vehicle-treated hPer2 oscillation, slightly delaying the suggest that glucocorticoids and retinoids may have drop of the hPer2 peak, which has been previously reopposing effects and therefore may utilize different ported (Balsalobre et al., 1998) . mechanisms to reset peripheral clock oscillations. Finally, mice maintained in constant darkness were Previous observations have hinted at a circadian role injected intraperitoneally with tRA to address whether for retinoid receptors and vitamin A. For example, tarit could delay mPer2 oscillations in vivo. tRA dissolved geted disruption of the retinoid-related orphan receptor, in DMSO or DMSO alone was injected at circadian time ROR␤, extends the period length (tau) of the free-running (CT) 9, and hearts and aortae were harvested at CT9, activity rhythm in mice and mildly affects circadian CT12, CT15, CT18, and CT21. RPA analysis of mPer2 rhythmicity (Andre et al., 1998). Additionally the interlevels in retinoic acid-treated animals compared to vehiphotoreceptor retinol binding protein (IRBP) has been cle-treated animals revealed that the mPer2 peak was shown to undergo circadian variation in zebrafish (Radelayed in both the aorta and heart by 3 hr upon tRA jendran et al., 1996), and recently murine cellular retinol treatment ( Figure 7C) . binding protein (mCRBP1), whose function is essential for vitamin A homeostasis, was observed to be a clockDiscussion controlled gene in the liver (Zheng et al., 2001 ). Interestingly, RBP, a retinoid binding protein is a member of We report a mechanism whereby peripheral circadian the lipocalin protein family which resembles the novel oscillators may be regulated by humoral factors. This Drosophila takeout (TO) gene superfamily, at least one involves a novel, ligand-dependent interaction between member of which is controlled by the clock and affects the retinoid receptors, RXR␣ and RAR␣, and the bHLHfeeding behavior (Sarov-Blat et al., 2000) . Some of these PAS circadian transcription factors, CLOCK and MOP4, observations indicate a role for retinoids, not only in which directly affects clock function. This mechanism peripheral circadian physiology, but also in functions that may be directly controlled by the brain. Our work pertains to a peripheral vascular clock, which is of po- 
